Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
57.65
-0.26 (-0.45%)
Apr 16, 2026, 1:48 PM EDT - Market open
Monopar Therapeutics Market Cap
Monopar Therapeutics has a market cap or net worth of $385.8 million as of April 16, 2026. Its market cap has increased by 73.35% in one year.
Market Cap
385.80M
Enterprise Value
247.39M
1-Year Change
73.35%
Ranking
Category
Stock Price
$57.65
Market Cap Chart
Since December 19, 2019, Monopar Therapeutics's market cap has increased from $276.16M to $385.80M, an increase of 39.70%. That is a compound annual growth rate of 5.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 387.54M | -11.19% |
| Dec 31, 2025 | 436.37M | 225.25% |
| Dec 31, 2024 | 134.17M | 2,552.79% |
| Dec 29, 2023 | 5.06M | -83.48% |
| Dec 30, 2022 | 30.62M | -24.23% |
| Dec 31, 2021 | 40.42M | -42.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ginkgo Bioworks Holdings | 388.82M |
| Puma Biotechnology | 385.14M |
| Greenwich LifeSciences | 380.86M |
| Lineage Cell Therapeutics | 376.12M |
| Nautilus Biotechnology | 375.90M |
| X4 Pharmaceuticals | 375.50M |
| Neumora Therapeutics | 375.00M |
| Rezolute | 374.98M |